Koefisien utang jangka dawa marang modal 180lifesciences.com (ATNF)

ETHZilla Corporation (ATNF) is building a team of Web3 experts, offering remote work and tokens. The company is developing treatments for arthritis and fibrosis via an anti-TNF platform. The market capitalization trend at the level of 1.09 reflects the asset's current price action. Future growth will be supported by the full robotization of fintech processes and autonomous smart contract verification, eliminating software constraints.

Investors utilize fundamental metrics to assess the financial stability of an issuer. This indicator calculates the proportion of long-term liabilities relative to equity to determine the level of debt load. By analyzing the ratio of long-term loans to equity, one can identify the balance between expansion and risk. For ETHZilla Corporation (ATNF), this is critical when procuring capacity for HPC. Low reliance on borrowed funds amidst fierce competition ensures business viability.